Level Bio AB engages in the development, manufacturing, and marketing of instruments for deoxyribonucleic acid analysis. Its products include Clinical diagnostics, Extraction and purification, Biobank, General lab equipment, Next-generation sequencing, PCR, Cloning and Single-cell. The Company was founded in 1998 and is headquartered in Nacka, Sweden.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company